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ABSTRACT
Diabetic nephropathy (DN) is clinically characterized by proteinuria. Many studies tried to demonstrate
a relationship between proteinuria and changes in nephrin in various forms of glomerular diseases
including DN, but the results are not consistent. Glomerular hypertrophy occurs in DN, yet hypertrophy
does not develop in all glomeruli concurrently. For investigation of the differences in nephrin expression
according to glomerular size, glomeruli were isolated from 10 control and 10 streptozotocin-induced
diabetic rats at 6 wk after the induction of diabetes by a sieving technique using sieves with pore sizes
of 250, 150, 125, and 75 m. Glomeruli then were classified into large glomeruli (LG; on the 125-m
sieve) and small glomeruli (SG; on the 75-m sieve) groups. Glomerular volumes were determined using
an image analyzer, and mRNA and protein expression was determined by real-time PCR and Western
blot, respectively. The mean volumes of diabetic LG (1.51  0.06  106 m3) and control LG (1.37 
0.05  106 m3) were significantly higher than those of diabetic SG (0.94  0.03  106 m3) and control
SG (0.87  0.03  106 m3; P  0.01). Nephrin mRNA expression was significantly reduced in the
diabetic LG group compared with the diabetic SG and control glomeruli groups (P  0.05). In contrast,
nephrin mRNA expression was significantly higher in the diabetic SG group compared with the diabetic
LG and control glomeruli groups (P  0.05). Even after correction for 18s rRNA and Wilms’ tumor-1
mRNA expression, the differences in nephrin mRNA expression remained significant. The expression of
nephrin protein showed a similar pattern to the mRNA expression. In conclusion, these data suggest that
the nephrin gene is differentially expressed according to glomerular size. Furthermore, more hypertro-
phied glomeruli with lesser nephrin expression may be responsible for albuminuria in the early stage of
DN.
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Diabetic nephropathy (DN), the leading cause of
ESRD in the United States,1 is clinically character-
ized by proteinuria.2 The underlying pathologic
change responsible for proteinuria in various glo-
merular diseases is the loss of size-selective and/or
charge-selective properties of the glomerular filtra-
tion barrier.3–7 The glomerular filtration barrier is
composed of three layers: A fenestrated endothelial
layer, a glomerular basement membrane (GBM),
and podocyte foot processes connected by a slit di-
aphragm. Traditionally, the GBM has been consid-
ered a coarse filter that restricts large molecules,
whereas the slit diaphragmwas thought to function
as a fine filter that contributes to ultimate size selec-
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tivity, permitting permeability only to molecules that are
smaller than albumin.8
Nephrin, a product of the NPHS1 gene that is mutated in
patients with congenital nephrotic syndrome of the Finnish
type,9 was the first protein demonstrated to comprise the slit
diaphragm.10,11 Experiments that were designed to demon-
strate a relationship between changes in nephrin expression
and/or localization and proteinuria in various forms of glo-
merular diseases, including DN, have been inconsistent.12–19 A
reduction in nephrin expression has been observed in experi-
mental glomerular diseases12 and in adult patients with pri-
mary acquired nephrotic syndrome15 but not in pediatric pa-
tients with glomerular diseases.16 In cases of experimental DN,
one study demonstrated a reduction in nephrin mRNA and
protein expressions in streptozotocin-induced diabetic spon-
taneously hypertensive rats,14 whereas another study in strep-
tozotocin-induced diabetic rats and in nonobese diabetic mice
revealed an increase in nephrin mRNA levels.13 The reasons
for the divergence of changes in nephrin expression in DN are
not clear, but differences between species, duration of diabe-
tes, or accompanying hypertension may contribute to these
disparities.
Most studies on the glomerular expression of certain mol-
ecules have been performed with glomeruli that were isolated
by eithermicrodissection or a sieving technique. At the time of
microdissection, especially in studies with diabetic glomeruli,
it is apparent that all of the glomeruli are not the same in size.
A difference in gene expression according to the size of glomer-
uli may exist but has never been studied.We hypothesized that
differential gene expression might occur depending on glo-
merular size and that the differences in glomerular size as a
result of diverse isolation techniques could lead to apparent
discordance of gene expression. In this study, we investigated
the differences in nephrin expression between relatively small
and large glomeruli that were isolated from diabetic rats. We
focused on the expression of nephrin, the most important fil-
tration barrier–associated molecule, because of the conflicting
reports on its expression patterns in DN.
RESULTS
Animal Data
All rats gained weight during the 6-wk experimental period,
but weight gain was higher in control compared with diabetic
rats (P  0.01). The ratio of kidney weight to body weight in
diabetic rats (1.07  0.04%) was significantly higher than in
control rats (0.64 0.02%; P 0.05).
The mean blood glucose levels of control and diabetic rats
were 101.7  1.9 and 483.3  7.3 mg/dl, respectively (P 
0.01). Compared with the control group (0.29  0.04 mg/d),
24-h urinary albumin excretion was significantly higher in the
diabetic group (1.09 0.17 mg/d; P 0.05; Table 1).
Glomerular Volume
We first examined the volume of glomeruli that were found on
the 125- and 75-msieves. Themean volumes of diabetic large
glomeruli (LG; 1.51  0.06  106 m3) and control LG
(1.37 0.05 106 m3) were significantly higher than those
of diabetic small glomeruli (SG; 0.94  0.03  106 m3) and
control SG (0.87 0.03 106m3; P 0.01; Figures 1 and 2).
The proportions of decapsulated glomeruli on the 125-m
sieve in control and diabetic rats were 89.6  3.4 and 91.3 
5.7% and on the 75-msievewere 92.9 2.7 and 92.0 3.1%,
respectively.
Glomerular Nephrin mRNA Expression
We next examined the changes of glomerular nephrin mRNA
expression according to the size of glomeruli. Nephrin mRNA
expression was significantly reduced in diabetic LG (0.49 
0.10) compared with diabetic SG (1.71  0.21) and control
glomeruli (SG reference value 1; LG 1.05  0.16; P  0.05),
whereas its expression was significantly higher in diabetic SG
compared with diabetic LG and control glomeruli (P  0.05;
Figure 3A). In contrast, there was no statistically significant
difference in glomerular 18s rRNA and Wilms’ tumor-1
(WT-1) mRNA expression among the four groups (data not
shown). Even after correction for 18s rRNA expression, the
differences in nephrin mRNA expression between groups re-
mained significant (P 0.05; Figure 3B).
Table 1. Body weight, kidney weight, kidney weight/body
weight, blood glucose, and 24-h urinary albumin excretion
of the two groups
Parameter
Control
(n  10)
Diabetic
(n  10)
Body weight after 6 wk (g) 418.00  5.00 295.00  4.00a
Kidney weight (g) 2.69  0.05 3.15  0.07b
Kidney weight/body weight (%) 0.64  0.02 1.07  0.04b
Blood glucose (mg/dl) 101.70  1.90 483.30  7.30a
24-h urinary albumin excretion
(mg/d)
0.29  0.04 1.09  0.17b
aP  0.01 versus control.
bP  0.05 versus control.
Figure 1. A representative photograph of sieved glomeruli from
a diabetic rat. Diabetic large glomeruli (DM-LG; on the 125-m
sieve; B) were significantly larger than diabetic small glomeruli
(DM-SG; on the 75-m sieve; A). Magnification, 100.
BASIC RESEARCH www.jasn.org
2304 Journal of the American Society of Nephrology J Am Soc Nephrol 18: 2303–2310, 2007
Glomerular Nephrin Protein Expression
Figure 4 shows a representativeWestern blot with the lysates of
control SG, control LG, diabetic SG, and diabetic LG at 6 wk
after streptozotocin injection. Glomerular nephrin, both ex-
tracellular and intracellular, protein expression was increased
in diabetic SG, whereas there was a significant reduction in
nephrin protein expression in diabetic LG comparedwith con-
trol SG and control LG, as shown by nephrin mRNA expres-
sion. Densitometric quantification revealed 56 and 92% in-
creases in extracellular and intracellular nephrin protein
expression, respectively, in diabetic SG compared with control
SG (P  0.05). In contrast, extracellular and intracellular
nephrin protein expression was decreased by 77 and 86%, re-
spectively, in diabetic LG versus control SG (P 0.05). There
was no significant difference in nephrin protein expression
between control LG and control SG. -Actin and WT-1 pro-
tein expression tended to be higher in both control LG and
diabetic LG but did not reach statistical significance.
Total Glomerular Cells and Podocyte Numbers
Total glomerular cells and podocyte numberswere determined
with the toluidine blue–stained semithin sections (Figure 5).
There was a significant increase in the number of total glomer-
ular cells in diabetic (SG 692.1  21.8; LG 715.8  18.7/glo-
merulus) comparedwith corresponding control glomeruli (SG
654.8  16.0; LG 689.3  18.4/glomerulus; P  0.05). In ad-
dition, total glomerular cell numbers tended to be higher in
diabetic LG relative to diabetic SG but did not reach statistical
significance. However, the number of podocytes was compa-
rable among the four groups (control SG 170.6 6.9; control
LG 183.6  10.5; diabetic SG 168.8  7.0; and diabetic LG
171.7 8.8/glomerulus).
Electron Microscopic Findings
The foot processes of diabetic LGwere broader and flatter than
those of the other groups. Themean foot process width (FPW)
was significantly greater in diabetic LG (424.8  20.7 nm)
compared with control SG (306.2  6.5 nm; P  0.001),
whereas the mean slit pore length was significantly shorter in
diabetic LG (27.0 1.2 nm) relative to control SG (33.4 1.7
nm; P 0.01). In contrast, the mean FPW and slit pore length
in control LG (323.7  9.4 and 34.1  1.2 nm, respectively)
and diabetic SG (316.3 10.8 and 32.0 1.5 nm, respectively)
were similar to those in control SG. In addition, the number of
Figure 2. Mean glomerular volume in control small glomeruli
(C-SG), control large glomeruli (C-LG), DM-SG, and DM-LG
groups. The mean volumes of DM-LG (1.51  0.06  106 m3)
and C-LG (1.37  0.05  106 m3) were significantly higher than
those of DM-SG (0.94  0.03  106 m3) and C-SG (0.87 
0.03  106 m3). *P  0.01 versus C-SG and DM-SG.
Figure 3. (A) Nephrin mRNA expression in C-SG, C-LG, DM-SG,
and DM-LG groups. Nephrin mRNA expression was significantly
reduced in DM-LG (0.49  0.10) compared with DM-SG (1.71 
0.21) and control glomeruli (C-SG reference value 1; C-LG 1.05 
0.16), whereas its expression was significantly higher in DM-SG
compared with DM-LG and control glomeruli. Data are expressed
as fold changes of nephrin mRNA expression relative to C-SG. (B)
Even after correction for 18s rRNA expression, the differences in
nephrin mRNA expression between groups remained significant.
*P  0.05 versus control glomeruli and DM-LG; #P  0.05 versus
control glomeruli and DM-SG.
Figure 4. A representative Western blot with the lysates of C-SG,
C-LG, DM-SG, and DM-LG. Both extracellular nephrin (corre-
sponding to amino acids 974 to 987 mapping within an extracel-
lular fibronectin domain) and intracellular nephrin (corresponding
to amino acids 1243 to 1256 mapping within intracellular domain)
protein expression were increased in DM-SG, whereas there was
a significant reduction in nephrin protein expression in DM-LG
compared with C-SG and C-LG. -Actin and Wilms’ tumor-1
(WT-1) protein expression tended to be higher in both C-LG and
DM-LG but did not reach statistical significance.
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slit pores per 100 m of GBMwas significantly less in diabetic
LG (182.9 7.1) versus control SG (260.7 5.6) and diabetic
SG (248.2  6.2; P  0.005), and the GBM was significantly
thicker in diabetic LG compared with diabetic SG (P  0.01)
and control glomeruli (P 0.001; Figure 5; Table 2).
Correlation between Nephrin mRNA Expression and
FPW
Pearson correlation analysis revealed that there was a signifi-
cant inverse correlation between the magnitude of nephrin
mRNAexpression and themeanFPW(R0.571,P 0.005;
Figure 6).
DISCUSSION
In this study, we show that nephrinmRNAand protein expres-
sion in diabetic glomeruli varied according to the size of glo-
meruli. These findings suggest that glomerular isolation by a
sieving technique with sieves of various pore sizes or various
kidney sizes may lead to diverse results in the expression of
certain genes. Finally, on the basis of the finding that nephrin
expression is diminished in diabetic LG, we suggest that albu-
minuriamay arise first inmore hypertrophied glomeruli in the
early stage of DN.
The slit diaphragm, which bridges adjacent foot processes
derived from different podocytes, functions as the ultimate
molecular size filter with 4 14-nm-sized pores.20 Themolec-
ular structure of the slit diaphragm is still unclear, but recent
studies have revealed a few genes located at the region of the slit
Figure 6. Correlation between nephrin mRNA expression and
FPW in C-SG, C-LG, DM-SG, and DM-LG. There was a significant
inverse correlation between the magnitude of nephrin mRNA
expression and the mean FPW (R  0.571, P  0.005).
Figure 5. Representative toluidine blue–stained semithin section of DM-LG (A) and electron microscopic photographs of foot
processes in C-SG (B), C-LG (C), DM-SG (D), and DM-LG (E) groups. The foot processes of DM-LG were broader and flatter than those
of the other groups. The mean foot process width (FPW) was significantly greater in DM-LG, whereas the mean slit pore length was
significantly shorter in DM-LG compared with the other groups. Magnifications: 400 in A; 50,000 in B through E.
Table 2. Electron microscopic findings in the four groupsa
Parameter
Control Diabetic
SG LG SG LG
Foot process width (nm) 306.2  6.5 323.7  9.4 316.3  10.8 424.8  20.7b
Slit pore length (nm) 33.4  1.7 34.1  1.2 32.0  1.5 27.0  1.2c
No. of slit pores (per 100 m) 260.7  5.6 273.3  6.0 248.2  6.2 182.9  7.1d
GBM thickness (nm) 197.8  11.7 205.3  9.8 222.3  13.2 268.2  12.9e
aGBM, glomerular basement membrane; LG, large glomeruli; SG, small glomeruli.
bP  0.001 versus other groups.
cP  0.01 versus other groups.
dP  0.005 versus other groups.
eP  0.001 versus control groups; P  0.01 versus diabetic SG.
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diaphragm. Nephrin, a product of theNPHS1 gene that is mu-
tated in patients with congenital nephrotic syndrome of the
Finnish type,9 was the first protein demonstrated to comprise
the slit diaphragm10,11 and has been suggested to play a critical
role in the pathogenesis of proteinuria in glomerular disease,
including DN. Because proteinuria is a cardinal feature of DN,
the contribution of changes in nephrin expression to protein-
uria in DN has also been studied, but the results were not
consistent. Bonnet et al.14 demonstrated a reduction in neph-
rin mRNA and protein expression in streptozotocin-induced
diabetic spontaneously hypertensive rats at 32 wk after the in-
duction of diabetes. A recent study also demonstrated dimin-
ished nephrin expression and altered nephrin localization in
biopsies of patients with nephropathy from both type 1 and
type 2 diabetes.17 In contrast, Aaltonen et al.13 observed an
increase in nephrin mRNA levels in streptozotocin-induced
diabetic rats and in nonobese diabetic mice even before the
development of significant albuminuria. In another study, an-
giotensin II, an importantmediator in the pathogenesis of DN,
infused byminipump in rats increased nephrinmRNA expres-
sion as assessed by real-time PCR and quantitative in situ hy-
bridization.21 The reasons for the divergence of changes in
nephrin expression in DN may be due to a variety of underly-
ing causes, including but not limited to differences in species,
duration of diabetes, and accompanying hypertension. How-
ever, we submit that the previously observed differences in
nephrin expression could be attributed to the variation in the
methods used for glomerular isolation.When the sieving tech-
nique was used for the isolation of diabetic glomeruli, many of
the hypertrophied diabetic glomeruli could not pass through
the second to the last sieve, thus leading to data that reflected
changes in only the less hypertrophied but not themore hyper-
trophied glomeruli.
Kidney size is typically increased in diabetes, even at the
time of diagnosis.22 This is primarily due to glomerular and
tubular hypertrophy. The increase in the number of glomeru-
lar cells, extracellular matrix accumulation, and the increase in
capillary number and size all contribute to glomerular hyper-
trophy. In this study, we also observed a significant increase in
total glomerular cell number in diabetic glomeruli compared
with control glomeruli despite of comparable podocyte num-
bers, suggesting that the increase in glomerular cell number
was mainly attributed to the increase in the number of mesan-
gial cells and endothelial cells, partly contributing to glomeru-
lar hypertrophy. A recent study used x-ray microcomputed
tomography to measure the glomerular volume of the Otsuka
Long-Evans Tokushima Fatty (OLETF) rat.23 This study re-
vealed that glomerular volume was significantly larger in the
OLETF rats compared with the age-matched controls of the
Long Evans Tokushima Lean (LETO) rats. However, when
glomerular volume was normalized to kidney weight or body
weight, the two groups were comparable. It is interesting that
scattering of glomerular volume, expressed as a coefficient
variation (SD/mean), was significantly larger in OLETF rats
comparedwith LETO rats even after normalization, suggesting
more heterogeneity in the glomerular volume distribution.
Many other investigators also observed that patients with type
2 diabetes showedmuch variability in glomerulopathy and tu-
bulointerstitial lesions.24,25 Such variation has resulted in dif-
ficulty in determining a sensitive histologic parameter for as-
certaining the early stage of DN. In contrast, glomerular
abnormalities in type 1 diabetes are known to bemore uniform
compared with type 2 diabetes.25 In this study, the proportion
of glomeruli on the 125-m sieve to total glomeruli was signif-
icantly higher in 6-wk diabetic rats compared with control rats
(3.50  0.31 versus 0.64  0.14%; P  0.001); therefore, we
surmised that the majority of the glomeruli in the diabetic LG
group were more hypertrophied diabetic glomeruli, which
may be more affected by the diabetic milieu compared with
diabetic SG. An increase in total cell number, albeit statistically
insignificant, and a significant increase in GBM thickness in
diabetic LG compared with diabetic SG also suggest that more
hypertrophied glomeruli are included in the diabetic LG
group. These results suggest that the same inconsistent glo-
merular changes occur in type 1 diabetes as in type 2 diabetes.
A recent study found that variation in nephrin expression in
biopsies of patients with nephropathy from both type 1 and
type 2 diabetes was larger compared with control patients.17
This finding partly supports our results describing changes in
nephrin expression. Because a previous study by Sanden et al.26
demonstrated that glomeruli in the inner cortex were statisti-
cally larger than glomeruli from the outer cortex and Artacho-
Perula et al.27 showed that degree of hypertrophy was compa-
rable among superficial, midcortical, and juxtamedullary
glomeruli, there is a possibility that glomeruli in the diabetic
LG are located more deeply in the renal cortex, but further
study will be necessary to confirm the location within the renal
cortex of more hypertrophied glomeruli as well as the factors
that dictate this change.
The number of podocytes is known to decrease in the glo-
meruli of patients with type 1 diabetes of all ages, with reduced
podocyte number even in diabetes of short duration.28 Analy-
sis of kidney biopsies from Pima Indians with type 2 diabetes
also demonstrated that individuals with clinical nephropathy
exhibited broadening of podocyte foot processes associated
with a reduction in the number of podocytes per glomerulus.29
To exclude the possibility that the decrease in nephrin expres-
sion in diabetic LGwas associatedwith a reduction in podocyte
number, we reevaluated nephrin protein expression by nor-
malizing it withWT-1 protein expression as well as with podo-
cyte number. Even after normalization, nephrin protein ex-
pression in diabetic LG remained significantly lower compared
with control glomeruli. Encapsulated glomeruli that contain
the Bowman’s capsule are larger than decapsulated glomeruli.
It has been reported that when glomerular isolation was per-
formed using a sieving technique, the proportions of decapsu-
lated and encapsulated glomeruli were 86.0 6.0 and 11.0
5.0%, respectively.30 In this study, we observed nearly the same
proportion of decapsulated glomeruli (approximately 90%)
from the 125- and 75-m sieves. These findings suggest that
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the reduction of nephrin mRNA and protein expression in
diabetic LG is attributed neither to the decrease in podocyte
number nor to the presence of a greater number of encapsu-
lated glomeruli.
Recently, it was suggested that nephrin acts as a signaling
molecule that can activate the mitogen-activated protein ki-
nase pathway and may influence podocyte survival.31,32 Fur-
thermore, a recent study using transgenic mice demonstrated
that nephrin was transcriptionally activated byWT-1.33 In this
study, however, we observed that changes in nephrin and
WT-1 expression did not coincide. Even thoughWT-1 expres-
sion was slightly increased in glomeruli on the 125-m sieve,
nephrin expression was significantly reduced in those glomer-
uli. Further verification is necessary to determine whether the
data from transgenic mice are applicable to non–genetically
modified animal experiments in the future. Moreover, we also
observed an increase in nephrin expression in glomeruli from
the 75-m sieve, which agrees with the results of the study by
Aaltonen et al.13 It was difficult to interpret the meaning of an
increase in nephrin expression in diabetic SG, but a compen-
satory phenomenon for decreased nephrin expression in dia-
betic LG or increased signaling events could be explanations
for this observation.
In addition to the alternations in the expression of podo-
cyte-associated molecules, proteinuria is closely linked to the
ultrastructural changes in podocytes in DN. Increased FPW
along with reduced slit pore length has been demonstrated in
patients with diabetes and in animal model of diabetes.34,35
Moreover, Berg et al.34 observed a strong correlation between
urinary albumin excretion and FPW in patients with type 1
diabetes, whereas Koop et al.36 showed that the mean width of
the podocyte foot processes was inversely correlated with
nephrin expression in various glomerular diseases. In this
study, we found a significant increase in the mean FPW and a
significant decrease in slit pore length along with a significant
decrease in nephrin expression in diabetic LG but not in dia-
betic SG, supporting our hypothesis that more hypertrophied
glomeruli are responsible for albuminuria in the early DN.
Nephrin mRNA and protein expression is decreased in
more hypertrophied glomeruli in early experimental diabetes,
whereas nephrin expression is increased in the relatively
smaller glomeruli. These data suggest that the expression of
certain genes is differentiated according to the size of glomeruli
and thatmore hypertrophied glomerulimay be responsible for
albuminuria in the early stage of DN.
CONCISE METHODS
Animals
All animal studies were conducted using a protocol approved by the
committee for the care and use of laboratory animals of Yonsei Uni-
versity College of Medicine. Twenty male Sprague-Dawley rats that
weighed 250 to 280 g were studied. Ten rats were administered an
injection of diluent (control) and 10 were administered an injection
of 65 mg/kg streptozotocin intraperitoneally (diabetic). Blood glu-
cose levels were measured 3 d after the streptozotocin injection to
confirm the development of diabetes. The rats were given free access
to water and standard laboratory diet during the 6-wk study period.
All rats were killed after 6wk.Whenwemeasured the urinary albumin
excretion in diabetic rats, a statistically significant increase in urinary
albumin excretion was observed for the first time at 6 wk after strep-
tozotocin injection. Because the purpose of this study was to examine
the changes of nephrin expression in a point of albuminuria, we used
6-wk diabetic rats.
Body weights were checked weekly, and kidney weights were mea-
sured when the rats were killed. Serum glucose was measured weekly,
and 24-h urinary albumin was measured when the rats were killed.
Blood glucose was measured by glucometer, and 24-h urinary albu-
min excretion was determined by ELISA (Nephrat II; Exocell, Phila-
delphia, PA).
Glomerular Isolation
Glomeruli were isolated by a sieving technique using sieves with pore
sizes of 250, 150, 125, and 75m.Because the juxtamedullary glomer-
uli are known to be larger than superficial and midcortical glomeruli
in control and streptozotocin-induced diabetic rats,27 we tried to use
only the superficial and midcortical tissues for glomerular isolation.
Glomeruli were collected under an inverted microscope to minimize
tubular contamination. We classified glomeruli into LG (on the
125-m sieve) and SG (on the 75-m sieve) groups. For the control
glomeruli, glomeruli on the 125-m sieve from 3 to 4 control rats
were pooled, because there were few glomeruli on the 125-m sieve
from the individual samples of the control rats. In addition, we deter-
mined the proportion of encapsulated and decapsulated glomeruli on
both the 125- and 75-m sieves.
Morphometric Measurement of Glomerular Volume
Glomerular volume (VG) was calculated as described previously.37
Briefly, photographs of 50 glomeruli were taken using a digital camera
at the time of sieving, and the surface areas were traced using a com-
puter-assisted color image analyzer Image-Pro (version 2.0; Media
Cybernetics, Silver Spring,MD).VGwas calculated using the equation
VG 4/3(area/)
3/2.
Total RNA Extraction and Reverse Transcription
Glomeruli on the 125-m (control LG and diabetic LG) and 75-m
sieves (control SG and diabetic SG) were put in a solution of vanadyl
ribonucleoside complex; and 300 glomeruli were counted at 4°C,
rinsed, and transferred to three tubes (100 glomeruli per tube) that
contained RNAse inhibitor. Total RNA was extracted and reverse-
transcribed as described previously.38
Real-Time PCR
The primers used for nephrin, 18s, and WT-1 amplification were as
follows: nephrin sense 5-CCTGCACCACCAACTGCTTAGC-3, an-
tisense 5-CCAGTGAGCTTCCCGTTCAGC-3; 18s sense 5-CGT-
GAGAGTGTCTAACGGG-3, antisense 5-CGAGTCAGGCATTT-
GGTCC-3; andWT-1 sense 5-CGTCCTTTCATGTGTGCATACC-
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3, antisense 5-GTGCTTCCGGCTATGCATCT-3. cDNA from 0.5
glomeruli per reaction tube were used for amplification.
With the use of the ABI PRISM 7700 Sequence Detection System
(Applied Biosystems, Foster City, CA), PCR was performed with a
total volume of 20 l in each well, containing 10 l of SYBR Green
PCRMaster Mix (Applied Biosystems), 5 l of cDNA, and 5 pmol of
sense and antisense primers. Primer concentrations were determined
by preliminary experiments that analyzed the optimal concentrations
of each primer. Each sample was run in triplicate in separate tubes to
permit quantification of the gene normalized to the 18s. The PCR
conditions used were as follows: For 18s, 35 cycles of denaturation at
94.5°C for 30 s, annealing at 60°C for 30 s, and extension at 72°C for 1
min; and for nephrin and WT-1, 40 cycles of denaturation at 94.5°C
for 30 s, annealing at 57°C for 30 s, and extension at 72°C for 30 s.
Initial heating at 95°C for 9 min and final extension at 72°C for 7 min
were performed for all PCR.
After real-time PCR, the temperature was increased from 60 to
95°C at a rate of 2°C/min to construct a melting curve. A control
without cDNAwas run in parallel with each assay. The cDNA content
of each specimen was determined using a comparative CT method
with 2CT. The results are given as relative expression of nephrin
normalized to the 18s housekeeping gene. Signals from control SG
were assigned a relative value of 1.0. In pilot experiments, PCR prod-
ucts that were run on agarose gels revealed a single band.
Western Blot Analysis
Counted glomeruli were lysed in SDS sample buffer (2% SDS, 10mM
Tris-HCl [pH 6.8], and 10% [vol/vol] glycerol), treatedwith Laemmli
sample buffer, heated at 100°C for 5 min, and electrophoresed in an
8% acrylamide denaturing SDS-polyacrylamide gel. Proteins were
then transferred to a Hybond-ECL membrane using a Hoeffer semi-
dry blotting apparatus (Hoeffer Instruments, San Francisco, CA), and
the membrane was then incubated in blocking buffer A (1 PBS,
0.1% Tween-20, and 8% nonfat milk) for 1 h at room temperature,
followed by an overnight incubation at 4°C in a 1:2000 dilution of
polyclonal antibodies to extracellular or intracellular domain of
nephrin (Progen, Heidelberg, Germany) or polyclonal antibodies to
WT-1 (Santa Cruz Biotechnology, Santa Cruz, CA) or -actin (Santa
Cruz Biotechnology). The membrane was then washed once for 15
min and twice for 5 min in 1 PBS with 0.1% Tween-20. Next, the
membrane was incubated in buffer A that contained a 1:1000 dilution
of horseradish peroxidase–linked goat anti-rabbit IgG (Amersham
Life Science, Arlington Heights, IL). The washes were repeated, and
the membrane was developed with a chemiluminescent agent (ECL;
Amersham Life Science).
Electron Microscopy
For transmission electron microscopy, isolated glomeruli were fixed
in 50 mM sodium cacodylate buffer (pH 7.4) that contained 2% glu-
taraldehyde in paraformaldehyde for 30 min at 32°C, postfixed in 1%
OsO4 for 2 h at 4°C, and dehydrated by treatment with a graded series
of ethanol (5 min each in 50, 60, 70, 80, 90, and 95% and twice in
100%). After that, isolated glomeruli were treated with propylene
oxide and embedded in Epon according to standard procedures, and
the glomeruli were localized in the semithin sections stained with tolu-
idine blue. Sectionswere cut using anUltracutRultratome (Leica,Wetz-
lar, Germany) and counterstained with 8% uranyl acetate and lead ci-
trate. Transmission electron microscopy was performed using a JEOL
JSM 1011microscope (Tokyo, Japan) operating at 80 kV and eight to 10
pictures, covering one or two glomerular cross-sections, were photo-
graphed in a random and unbiased manner. The images magnified to
15,000 times were used to measure the GBM length and the number of
slit pores, and the images at 50,000 or 100,000 magnification were
used to determine the FPW, the slit pore length, and theGBM thickness.
A foot process was defined as any connected epithelial segment
butting on the basement membrane, between two neighboring filtra-
tion pores or slits. From each photograph, the arithmetic mean of the
FPW was calculated using the following equation as described previ-
ously36: FPW /4	GBM length/	 slits. 	 slits is the total num-
ber of slit pores counted in each picture, and	GBM length is the total
GBM length measured in each picture. The correction factor of /4
serves to correct for presumed random variation in the angle of sec-
tion relative to the long axis of the podocyte. The slit pore length was
expressed as per 100 m of GBM.
GBM thickness was determined at five different sites, where the
epithelial and endothelial cytoplasmic membranes were clearly visi-
ble, using the technique described by Osawa et al.39 Measurements
were undertaken perpendicularly from the endothelial cytoplasmic
membrane to the outer lining of the lamina rara externa underneath
the cytoplasmicmembrane of the epithelial foot process. Tangentially
sectioned GBM and areas of GBM attached to bars of mesangial ma-
trix were excluded from the analysis.
Total glomerular cells and podocyte numbers were determined by
the exhaustive count method as described previously.40 Two adjacent
toluidine blue–stained semithin sections 3mapart were observed in
pairs at a magnification of 2000, and the nuclei present in the top
section but not in the bottom sectionwere counted and summed. Ten
glomeruli in five rats from each group and 13 to 15 semithin sections
from the midglomerular area were examined.
Statistical Analyses
All values are expressed as the means SEM. Statistical analysis was
performed using the statistical package SPSS for Windows (version
11.0; SPSS, Chicago, IL). Results were analyzed using the Kruskal-
Wallis nonparametric test for multiple comparisons. Significant dif-
ferences by the Kruskal-Wallis test were further confirmed by the
Mann-Whitney U test. The relationship between nephrin mRNA ex-
pression and FPW was determined using Pearson correlation test.
P 0.05 was considered to be statistically significant.
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